IMRIS and MDA to complete Image Guided Surgical Robotics Program

Top

Search EDI

IMRIS and MDA to complete Image Guided Surgical Robotics Program

Tuesday, September 20, 2011 at 01:43PM

First demonstration set for 2011 Congress of Neurological Surgeons in Washington, D.C.

Robotic surgery is a growing market: IMRIS hopes to be ready to seek regulatory approval for its MR guided surgical robot (not shown here) by 2012.

IMRIS Inc., providers of image-guided therapy solutions for the neurosurgical, cardiovascular and neurovascular markets, and MacDonald, Dettwiler and Associates Ltd. have announced an agreement to complete their collaborative development of IMRIS's MR guided surgical robot, a collaboration that began in 2010. The system is being designed to perform microsurgery and biopsy-stereotaxy on the brain, with sub-millimeter precision, bringing surgical robotics together with real time MR imaging in a fully integrated IMRIS surgical suite under the full control of the neurosurgeon. Ultimately, the technology is expected to extend into a broad range of surgical applications.

The system uses two robotic arms to manipulate MR-compatible tools at a microscopic level from a remote workstation. The surgeon sees detailed three-dimensional images of the brain and the surgical tools, and uses hand controllers equipped with enhanced touch sensation that allow the surgeon to feel tissue through the robotic arms and surgical tools and apply appropriate pressure as they operate.

A clinical trial utilizing the first generation of the robot on a cohort of 120 patients is currently underway at Calgary's Foothills Hospital. The first public demonstration of IMRIS' robotic technology will be at the Congress of Neurological Surgeons in Washington DC.

Under the terms of the multimillion-dollar agreement, MDA is IMRIS's development and preferred manufacturing partner for image-guided surgical robotics. The two companies have made significant progress in advancing the new IMRIS image guided surgical robotic system toward commercialization. Given current development plans, IMRIS anticipates being in a position to seek regulatory approval as early as the second quarter of 2012.

"Recognition of the benefits of medical robotics continues to grow, and market demand for these value adding capabilities is increasing around the world," said David Graves, CEO of IMRIS. "We believe the availability of surgical robotics within IMRIS's image guided surgery suites will prove very compelling for clinicians."

* SPECIAL DESIGN,

* SPECIAL TECHNOLOGY |

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

Post a New Comment

Enter your information below to add a new comment.

Author:

Author Email (optional):

Author URL (optional):

Post:

↓ | ↑

Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

IMPORTANT: No advice is offered or given in this article or this publication. PLEASE ALWAYS REFER TO AN EXPERT before acting on any information contained in any of our stories.
Copyright © 2006-10, Blogertize Publications (http://www.blogertize.com), except as otherwise indicated. Text may be excerpted UNALTERED with FULL CREDIT and LINK. PHOTOS MAY NOT BE COPIED, DOWNLOADED OR REPRODUCED WITHOUT PERMISSION. Note: Some photos of real people may be models used to illustrate the editorial concept. MISSION: "You Need to Know" Our publications are daily online newspapers and magazines (webzines), plus delivered Ezines. Our stories also appear on various newswire services and are picked up in other publications. Our reporters and journalists break or report stories and their sources and source information are protected by the doctrine of free press as expressed in the First Amendment, Reporter's Privilege statutes, and also the Canadian Charter of Rights and Freedoms. COMMENTS FROM USERS: We invite dialogue and comments from our readers and limit moderation to obscenity and privacy issues, however WE ACCEPT NO RESPONSIBILITY WHATSOEVER FOR THIS CONTENT. We believe in the doctrine of FREE SPEECH. COMMENTS AND MOST STORIES ARE FROM OUTSIDE CONTRIBUTORS AND READERS AND NOT A REFLECTION OF THE OPINIONS OF THIS MAGAZINE. The opinions expressed by our writers, columnists and reporters are their opinions and do not necessarily reflect the opinion of this magazine, its writers and staff, or Blogertize Publications.TM - Our magazine names are trademarked. Our publications team provide this ezine and web site and its contents in good faith but makes no representations or warranties of any kind with respect to this web site or its contents. We disclaim any representations and warranties, whether express or implied, including, but not limited to warranties of any kind. In addition, we do not represent or warrant that the information accessible via this web site or the products or services sold or given free on it are accurate, complete or current. Errors and Omissions Excepted. By using/visiting this site you agree that use information herein is at your own risk. PRIVACY: SPAM POLICY: We do not use, nor do we condone the use of unsolicited bulk email. Our email system is an opt-in only. Please report any incidents of unsolicited email coming from or mentioning our domain to editor AT blogeritze.com. All matters will be investigated and dealt with promptly. Jurisdiction: Any action or dispute arising from the use of information on this site will be deemed to have been undertaken and concluded in Toronto, Canada and will be interpreted, construed and enforced in all respects in accordance with the laws of Canada and all parties thereto shall submit to the exclusive jurisdiction of the Ontario courts. A visitor agrees that the applicable law to be applied shall, in all cases, be that of the city of the web site owner, namely, Toronto, Canada.